Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of May 21, 2026, SNDX trades at $20.23 with a market cap of $1.72B and a P/E ratio of -6.10. SNDX moved +4.08% today. Year to date, SNDX is -0.45%; over the trailing twelve months it is +90.44%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $39.91. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded SNDX stock?
Rallies tracks politician and congressional stock disclosures for SNDX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for SNDX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SNDX?
Yes. Rallies tracks politician and congressional stock disclosures for SNDX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SNDX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNDX. It does not provide personalized investment advice.
